Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
N Engl J Med
    July 2021
  1. JENKINS DJA, Dehghan M, Yusuf S
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality. Reply.
    N Engl J Med. 2021;385:379-380.
    >> Share

  2. KANTER M, Angadi S, Slavin J
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378-379.
    >> Share

  3. LEOW MK, Henry CJ
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378.
    >> Share

  4. JUNI P
    PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFR.
    N Engl J Med. 2021;385:370-371.
    >> Share

  5. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    >> Share

    June 2021
  6. GERSTEIN HC, Sattar N, Rosenstock J, Ramasundarahettige C, et al
    Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
    N Engl J Med. 2021 Jun 28. doi: 10.1056/NEJMoa2108269.
    >> Share

  7. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    >> Share

    May 2021
  8. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.
    >> Share

  9. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    >> Share

  10. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    >> Share

  11. PUYMIRAT E, Cayla G, Simon T, Steg PG, et al
    Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2104650.
    >> Share

  12. JONES WS, Mulder H, Wruck LM, Pencina MJ, et al
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137.
    >> Share

  13. RODRIGUEZ F, Harrington RA
    Antithrombotic Therapy after Acute Coronary Syndromes. Reply.
    N Engl J Med. 2021;384:1873-1874.
    >> Share

  14. PARADA BARCIA J, Raposeiras Roubin S, Abu-Assi E
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1873.
    >> Share

  15. BITTL JA
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1872-1873.
    >> Share

  16. KONIG MF, Sathiyakumar V, Phan CM, Schulman SP, et al
    Inside and Out.
    N Engl J Med. 2021;384:1753-1760.
    >> Share

    April 2021
  17. YUSUF S, Joseph P, Pais P
    Polypill in Persons without Cardiovascular Disease. Reply.
    N Engl J Med. 2021;384:1676-1677.
    >> Share

  18. CAINZOS-ACHIRICA M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675-1676.
    >> Share

  19. WALD N, Wald D, Law M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675.
    >> Share

  20. MESSERLI FH, Brguljan J, Bangalore S
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674-1675.
    >> Share

  21. ALAM A, Carey SA, Hall SA
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674.
    >> Share

  22. GALLIENI M, Paik JM, Fiorina P
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1673-1674.
    >> Share

  23. BHATT DL, Steg PG, Pitt B
    Cardiovascular Outcomes with Sotagliflozin. Reply.
    N Engl J Med. 2021;384:1471-1473.
    >> Share

  24. MARCHAND L, Villar E, Green L
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1471.
    >> Share

  25. BAGLIONI P
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1470-1471.
    >> Share

  26. KALYANI RR
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;384:1248-1260.
    >> Share

    March 2021
  27. KIM ESH
    Spontaneous Coronary-Artery Dissection. Reply.
    N Engl J Med. 2021;384:1077-1078.
    >> Share

  28. WANG X, Ge J
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    >> Share

  29. CAMPOCHIARO C, Tomelleri A, Dagna L
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2021;384:1077.
    >> Share

  30. GIBBONS GH, Seidman CE, Topol EJ
    Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
    N Engl J Med. 2021;384:785-788.
    >> Share

    February 2021
  31. FIOLET ATL, Cornel JH, Thompson PL
    Colchicine in Patients with Chronic Coronary Disease. Reply.
    N Engl J Med. 2021;384:778-779.
    >> Share

  32. D'AMARIO D, Rodolico D, Galli M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:778.
    >> Share

  33. LUCIJANIC M, Javor E, Skelin M
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777-778.
    >> Share

  34. FISCHER BG
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:777.
    >> Share

  35. GEBHARD C, Regitz-Zagrosek V
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776-777.
    >> Share

  36. KAISER D, Jackson CD
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2021;384:776.
    >> Share

  37. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
    >> Share

  38. RODRIGUEZ F, Harrington RA
    Management of Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:452-460.
    >> Share

    January 2021
  39. HUFFMAN MD, Patel A
    Polypills - A Central Strategy for Improving Cardiovascular Health.
    N Engl J Med. 2021;384:288-289.
    >> Share

  40. SCOTT NS, Thomas SS, DeFaria Yeh D, Fox AS, et al
    Case 2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
    N Engl J Med. 2021;384:272-282.
    >> Share

    December 2020
  41. KIM ESH
    Spontaneous Coronary-Artery Dissection.
    N Engl J Med. 2020;383:2358-2370.
    >> Share

    November 2020
  42. YUSUF S, Joseph P, Dans A, Gao P, et al
    Polypill with or without Aspirin in Persons without Cardiovascular Disease.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028220.
    >> Share

    October 2020
  43. LEE TH
    Seizing the Teachable Moment - Lessons from Eisenhower's Heart Attack.
    N Engl J Med. 2020;383:e100.
    >> Share

  44. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    >> Share

    September 2020
  45. CANNON CP, Pratley R, Dagogo-Jack S, Mancuso J, et al
    Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
    >> Share

  46. BANGALORE S, Maron DJ, Hochman JS
    Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply.
    N Engl J Med. 2020;383:1091-1092.
    >> Share

  47. YING T, Gill JS, Chadban S
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1091.
    >> Share

  48. AFSAR B, Elsurer Afsar R, Kanbay M
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090-1091.
    >> Share

  49. SHETTY HB, Shetty AH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    >> Share

  50. WEBSTER MWI, Stewart RAH
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020;383:1090.
    >> Share

  51. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1094.
    >> Share

  52. CHALIKIAS G, Tziakas D
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1094.
    >> Share

  53. BURTSCHER J, Millet GP, Burtscher M
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;383:1093.
    >> Share

  54. ANTMAN EM, Braunwald E
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    >> Share

  55. MARON DJ, Hochman JS
    Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
    N Engl J Med. 2020;383:e66.
    >> Share

  56. KARIMI GALOUGAHI K, Patel S, Adams M
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    >> Share

  57. VAN 'T HOF A, Crea F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    >> Share

  58. VAN MIEGHEM NM, Daemen J, Zijlstra F
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    >> Share

  59. TOMODA H
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    >> Share

  60. DANGAS G, Roumeliotis A, Giustino G
    Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020;383:e66.
    >> Share

    August 2020
  61. NIDORF SM, Fiolet ATL, Mosterd A, Eikelboom JW, et al
    Colchicine in Patients with Chronic Coronary Disease.
    N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372.
    >> Share

  62. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
    >> Share

  63. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    >> Share

  64. SCOTT AC, McDonald A, Roberts T, Martin C, et al
    Cardiovascular Telemedicine Program in Rural Australia.
    N Engl J Med. 2020;383:883-884.
    >> Share

  65. VERGALLO R, Crea F
    Atherosclerotic Plaque Healing.
    N Engl J Med. 2020;383:846-857.
    >> Share

  66. FERENCE BA, Ray KK, Nicholls SJ
    Mendelian Randomization Study of ACLY and Cardiovascular Disease. Reply.
    N Engl J Med. 2020;383:e50.
    >> Share

  67. HOLM H, Sulem P, Helgadottir A, Tragante V, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    >> Share

  68. DAMASK A, Paulding C, Baras A, Carey D, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    >> Share

  69. KLARIN D, O'Donnell CJ, Kathiresan S
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2020;383:e50.
    >> Share

    July 2020
  70. STONE GW, Serruys PW, Sabik JF
    PCI or CABG for Left Main Coronary Artery Disease. Reply.
    N Engl J Med. 2020;383:292-294.
    >> Share

  71. BAKAEEN FG, Svennson LG
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:292.
    >> Share

  72. KAPOOR S, Mulukutla S
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291-292.
    >> Share

  73. LOPEZ-AYALA P, Koechlin L, Mueller C
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:291.
    >> Share

  74. LOZANO I, Rondan J, Vegas JM
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290-291.
    >> Share

  75. TAGGART DP, Gaudino M
    PCI or CABG for Left Main Coronary Artery Disease.
    N Engl J Med. 2020;383:290.
    >> Share

  76. NEWTON-CHEH C, Zlotoff DA, Hung J, Rupasov A, et al
    Case 24-2020: A 44-Year-Old Woman with Chest Pain, Dyspnea, and Shock.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMcpc2004975.
    >> Share

    June 2020
  77. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;382:2238-2247.
    >> Share

  78. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 4. doi: 10.1056/NEJMc2021225.
    >> Share

  79. RUBIN EJ
    Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
    N Engl J Med. 2020 Jun 2. doi: 10.1056/NEJMe2020822.
    >> Share

    May 2020
  80. HIGANO CS
    Cardiovascular Disease and Androgen Axis-Targeted Drugs for Prostate Cancer.
    N Engl J Med. 2020 May 29. doi: 10.1056/NEJMe2016433.
    >> Share

  81. TSIMIKAS S, Karwatowska-Prokopczuk E, Xia S
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply.
    N Engl J Med. 2020;382:e65.
    >> Share

  82. FERRO CJ, Sarafidis P, Ortiz A
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    >> Share

  83. ANDREOTTI F, Maggioni AP
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    >> Share

  84. ALKHALIL M
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020;382:e65.
    >> Share

  85. SOLOMON MD, McNulty EJ, Rana JS, Leong TK, et al
    The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.
    N Engl J Med. 2020 May 19. doi: 10.1056/NEJMc2015630.
    >> Share

  86. MEHRA MR, Desai SS, Kuy S, Henry TD, et al
    Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
    N Engl J Med. 2020 May 1. doi: 10.1056/NEJMoa2007621.
    >> Share

    April 2020
  87. DE FILIPPO O, D'Ascenzo F, Angelini F, Bocchino PP, et al
    Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMc2009166.
    >> Share

  88. TARDIF JC, L'Allier PL, Guertin MC
    Low-Dose Colchicine after Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1668.
    >> Share

  89. CHIARITO M, Condorelli G, Stefanini GG
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667-1668.
    >> Share

  90. REINDL M, Metzler B, Reinstadler SJ
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1667.
    >> Share

  91. FURER V, Elkayam O, Caspi D
    Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2020;382:1666-1667.
    >> Share

  92. KITTLESON MM
    The Invisible Hand - Medical Care during the Pandemic.
    N Engl J Med. 2020;382:1586-1587.
    >> Share

  93. SPERTUS JA, Jones PG, Maron DJ, Mark DB, et al
    Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
    N Engl J Med. 2020;382:1619-1628.
    >> Share

  94. BANGALORE S, Sharma A, Slotwiner A, Yatskar L, et al
    ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009020.
    >> Share

  95. MEHTA SR, Wood DA, Cairns JA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction. Reply.
    N Engl J Med. 2020;382:1571-1572.
    >> Share

  96. DOENST T, Boning A, Thiele H
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1571.
    >> Share

  97. FERREIRA RM, Salis LHA, de Souza E Silva NA
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1570.
    >> Share

  98. BURGESS SN, Juergens CP, French JK
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569-1570.
    >> Share

  99. DESCHNER M, Glanz A
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    >> Share

  100. AUER J, Berent R, Gurtner F
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1569.
    >> Share

  101. BOGATY P, Brophy JM
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2020;382:1568.
    >> Share

  102. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    >> Share

    March 2020
  103. BANGALORE S, Maron DJ, O'Brien SM, Fleg JL, et al
    Management of Coronary Disease in Patients with Advanced Kidney Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915925.
    >> Share

  104. MARON DJ, Hochman JS, Reynolds HR, Bangalore S, et al
    Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915922.
    >> Share

  105. SPERTUS JA, Jones PG, Maron DJ, O'Brien SM, et al
    Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1916370.
    >> Share

  106. ANTMAN EM, Braunwald E
    Managing Stable Ischemic Heart Disease.
    N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMe2000239.
    >> Share

  107. WINDECKER S, Latib A, Kedhi E, Kirtane AJ, et al
    Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
    N Engl J Med. 2020;382:1208-1218.
    >> Share


  108. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2020;382:1078.
    >> Share

  109. BOHOSSIAN HB, Lopes EW, Roller LA, Ananthakrishnan AN, et al
    Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools.
    N Engl J Med. 2020;382:1042-1052.
    >> Share

    February 2020
  110. OLENSKI AR, Zimerman A, Coussens S, Jena AB, et al
    Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery.
    N Engl J Med. 2020;382:778-779.
    >> Share

    January 2020
  111. SCHUPKE S, Kastrati A
    Ticagrelor or Prasugrel in Acute Coronary Syndromes. Reply.
    N Engl J Med. 2020;382:487.
    >> Share

  112. SHARMA S, Lardizabal J, Sharma R
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:487.
    >> Share

  113. CARBONELL-PRAT B, Flores-Umanzor E, Brugaletta S
    Ticagrelor or Prasugrel in Acute Coronary Syndromes.
    N Engl J Med. 2020;382:486.
    >> Share

  114. WANG TJ, Munoz D, Blot WJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.
    N Engl J Med. 2020;382:95.
    >> Share

  115. BILAL U, Cainzos-Achirica M
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94-95.
    >> Share

  116. BRUGTS JJ
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2020;382:94.
    >> Share

  117. TSIMIKAS S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, et al
    Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
    N Engl J Med. 2020 Jan 1. doi: 10.1056/NEJMoa1905239.
    >> Share

    December 2019
  118. NEUMANN JT, Twerenbold R, Blankenberg S
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. Reply.
    N Engl J Med. 2019;381:2483.
    >> Share

  119. AKSOY A, Agirbasli M
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482-2483.
    >> Share

  120. LAU CS, Aw TC
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;381:2482.
    >> Share

  121. YASUDA S, Ogawa H
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Reply.
    N Engl J Med. 2019;381:2481.
    >> Share

  122. GREMMEL T
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480-2481.
    >> Share

  123. PATTI G, De Caterina R
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2480.
    >> Share

  124. MARQUIS-GRAVEL G, Roe MT
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019;381:2479-2480.
    >> Share

  125. PANZA JA, Velazquez EJ, Bonow RO
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. Reply.
    N Engl J Med. 2019;381:2374.
    >> Share

  126. SHARMA S, Sharma R, Lardizabal J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    >> Share

  127. NAPP LC, Bengel FM, Bauersachs J
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:2373.
    >> Share

  128. NAGEL E, Berry C
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. Reply.
    N Engl J Med. 2019;381:2277-2278.
    >> Share

  129. TEBALDI M, Biscaglia S, Campo G
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2277.
    >> Share

  130. DESCHNER M, Glanz A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276-2277.
    >> Share

  131. O'ROURKE MF, Adji A
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;381:2276.
    >> Share

    November 2019
  132. HUSAIN M, Donsmark M, Bain SC
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;381:2076-2077.
    >> Share

  133. ZWECK E, Westenfeld R, Szendroedi J
    Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;381:2075-2076.
    >> Share

  134. MEHRAN R, Baber U, Sharma SK, Cohen DJ, et al
    Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
    N Engl J Med. 2019;381:2032-2042.
    >> Share

  135. TARDIF JC, Kouz S, Waters DD, Bertrand OF, et al
    Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1912388.
    >> Share

  136. NEWBY LK
    Inflammation as a Treatment Target after Acute Myocardial Infarction.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMe1914378.
    >> Share

    October 2019

  137. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
    N Engl J Med. 2019;381:1789.
    >> Share

  138. BRIOSA E GALA A, Rawlins J
    Posterior-Wall Myocardial Infarction.
    N Engl J Med. 2019;381:e32.
    >> Share

  139. FLINT AC, Conell C, Bhatt DL
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. Reply.
    N Engl J Med. 2019;381:1692-1693.
    >> Share

  140. VERDECCHIA P, Angeli F, Reboldi G
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1691-1692.
    >> Share

  141. QUINN S, McEvoy JW
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690-1691.
    >> Share

  142. KOSTIS WJ, Kostis JB, Moreyra AE
    Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes.
    N Engl J Med. 2019;381:1690.
    >> Share

  143. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
    Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
    N Engl J Med. 2019;381:1664-1673.
    >> Share

  144. CLAASSENS DMF, Vos GJA, Bergmeijer TO, Hermanides RS, et al
    A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
    N Engl J Med. 2019;381:1621-1631.
    >> Share

  145. JNEID H
    Ticagrelor or Prasugrel in Acute Coronary Syndromes - The Winner Takes It All?
    N Engl J Med. 2019;381:1582-1585.
    >> Share

  146. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    >> Share

  147. KOBER L, Engstrom T
    A More COMPLETE Picture of Revascularization in STEMI.
    N Engl J Med. 2019;381:1472-1474.
    >> Share

    September 2019
  148. STONE GW, Kappetein AP, Sabik JF, Pocock SJ, et al
    Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.
    N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.
    >> Share

  149. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    >> Share

  150. YASUDA S, Kaikita K, Akao M, Ako J, et al
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMoa1904143.
    >> Share

  151. BECKER RC
    Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease.
    N Engl J Med. 2019 Sep 2. doi: 10.1056/NEJMe1910560.
    >> Share

  152. STEG PG, Bhatt DL, Simon T, Fox K, et al
    Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908077.
    >> Share

  153. BATES ER
    Antiplatelet Therapy in Patients with Coronary Disease and Type 2 Diabetes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMe1910813.
    >> Share

  154. MEHTA SR, Wood DA, Storey RF, Mehran R, et al
    Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1907775.
    >> Share

  155. SCHUPKE S, Neumann FJ, Menichelli M, Mayer K, et al
    Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908973.
    >> Share

    August 2019
  156. PANZA JA, Ellis AM, Al-Khalidi HR, Holly TA, et al
    Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.
    N Engl J Med. 2019;381:739-748.
    >> Share

    July 2019
  157. HARDIN CC, Malhotra R, Petranovic M, Klassen S, et al
    Case 23-2019: A 52-Year-Old Man with Fever, Cough, and Hypoxemia.
    N Engl J Med. 2019;381:359-369.
    >> Share

  158. FLINT AC, Conell C, Ren X, Banki NM, et al
    Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    N Engl J Med. 2019;381:243-251.
    >> Share

  159. LEMKES JS, Janssens GN, van Royen N
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. Reply.
    N Engl J Med. 2019;381:189-190.
    >> Share

  160. DE SILVA K, Perera D
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    >> Share

  161. KIM YJ, Kim WY
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:189.
    >> Share

  162. WALDMANN V, Bonnet G, Spaulding C
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188-189.
    >> Share

  163. DEGRELL P, Varenne O
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019;381:188.
    >> Share

    June 2019
  164. NEUMANN JT, Twerenbold R, Ojeda F, Sorensen NA, et al
    Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
    N Engl J Med. 2019;380:2529-2540.
    >> Share

  165. NAGEL E, Greenwood JP, McCann GP, Bettencourt N, et al
    Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
    N Engl J Med. 2019;380:2418-2428.
    >> Share

  166. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
    >> Share

  167. RIDKER PM
    Methotrexate for Prevention of Cardiovascular Events. Reply.
    N Engl J Med. 2019;380:2277.
    >> Share

  168. HUANG Y, Chan AW, Shear NH
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2277.
    >> Share

  169. VAN VOLLENHOVEN RF, Nurmohamed M
    Methotrexate for Prevention of Cardiovascular Events.
    N Engl J Med. 2019;380:2276-2277.
    >> Share

    May 2019
  170. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    >> Share

  171. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    >> Share

  172. SCHWARTZ GG, Steg PG, Szarek M
    Alirocumab after Acute Coronary Syndrome. Reply.
    N Engl J Med. 2019;380:2077.
    >> Share

  173. PIGNATELLI P, Camera M, Violi F
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    >> Share

  174. ENNEZAT PV, Hansen MR
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2076.
    >> Share

  175. LAN NSR, Yeap BB, Fegan PG
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075-2076.
    >> Share

  176. ALKHALIL M
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2075.
    >> Share

  177. GAO Y, Hou B
    Alirocumab after Acute Coronary Syndrome.
    N Engl J Med. 2019;380:2074-2075.
    >> Share

  178. THIELE H, Schneider S, Desch S
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock. Reply.
    N Engl J Med. 2019;380:1877.
    >> Share

  179. YAN F, Thall P, Yuan Y
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2019;380:1876-1877.
    >> Share

  180. WIVIOTT SD, Raz I, Sabatine MS
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2019;380:1881-1882.
    >> Share

  181. AKINCI B
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1881.
    >> Share

  182. BAGLIONI P
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2019;380:1880-1881.
    >> Share

    April 2019
  183. BHATT DL, Steg PG, Miller M
    Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.
    N Engl J Med. 2019;380:1678.
    >> Share

  184. BORGHI C, Fogacci F, Cicero AFG
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1678.
    >> Share

  185. CHAN LN
    Cardiovascular Risk Reduction with Icosapent Ethyl.
    N Engl J Med. 2019;380:1677.
    >> Share

  186. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction. Reply.
    N Engl J Med. 2019;380.
    >> Share

  187. FRANK RC, Hanidziar D
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380.
    >> Share

    March 2019
  188. LANDONI G, Lomivorotov VV, Nigro Neto C, Monaco F, et al
    Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery.
    N Engl J Med. 2019 Mar 19. doi: 10.1056/NEJMoa1816476.
    >> Share

  189. LEMKES JS, Janssens GN, van der Hoeven NW, Jewbali LSD, et al
    Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1816897.
    >> Share

  190. ABELLA BS, Gaieski DF
    Coronary Angiography after Cardiac Arrest - The Right Timing or the Right Patients?
    N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMe1901651.
    >> Share

  191. LOPES RD, Heizer G, Aronson R, Vora AN, et al
    Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMoa1817083.
    >> Share

  192. MEHTA SR
    Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI.
    N Engl J Med. 2019 Mar 17. doi: 10.1056/NEJMe1902214.
    >> Share

  193. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    >> Share

  194. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    >> Share

    February 2019
  195. RIDKER PM, Everett BM, Pradhan A, MacFadyen JG, et al
    Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
    N Engl J Med. 2019;380:752-762.
    >> Share

  196. FAUCHIER L, Clementy N, Bisson A
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:600.
    >> Share

  197. STECKER EC, Walsh MN
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599.
    >> Share


  198. Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2019;380:599-601.
    >> Share

    January 2019
  199. TAGGART DP, Benedetto U, Gerry S, Altman DG, et al
    Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.
    N Engl J Med. 2019;380:437-446.
    >> Share


  200. Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-300.
    >> Share

  201. CHEUNG BMY
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299-300.
    >> Share

  202. SANDHU AT, Maron DJ
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:299.
    >> Share

  203. BOGATY P, Brophy J
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298-9.
    >> Share

  204. KOROSOGLOU G, Giusca S
    Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
    N Engl J Med. 2019;380:298.
    >> Share

  205. MUSHER DM, Abers MS, Corrales-Medina VF
    Acute Infection and Myocardial Infarction.
    N Engl J Med. 2019;380:171-176.
    >> Share

  206. VERMA S, Mazer CD
    Open or Endoscopic Vein Harvesting for Coronary-Artery Bypass Grafting.
    N Engl J Med. 2019;380:189-191.
    >> Share

    December 2018
  207. MATSUURA H, Ohya M
    Coronary-Artery Occlusion from Kawasaki's Disease.
    N Engl J Med. 2018;379:e42.
    >> Share

  208. WADHERA RK, Bhatt DL
    Toward Precision Policy - The Case of Cardiovascular Care.
    N Engl J Med. 2018;379:2193-2195.
    >> Share

    November 2018
  209. BURNETT JR, Hooper AJ
    PCSK9 - A Journey to Cardiovascular Outcomes.
    N Engl J Med. 2018;379:2161-2162.
    >> Share

  210. KOPJAR T, Gasparovic H, Biocina B
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-7.
    >> Share

  211. REHMAN SM, Duggan SMJ
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    >> Share

  212. ALSAGHEIR A, Belley-Cote EP, Whitlock RP
    Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966.
    >> Share


  213. Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018;379:1966-1968.
    >> Share

  214. ZENATI MA, Bhatt DL, Bakaeen FG, Stock EM, et al
    Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass.
    N Engl J Med. 2018 Nov 11. doi: 10.1056/NEJMoa1812390.
    >> Share

  215. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1811403.
    >> Share

  216. MANSON JE, Cook NR, Lee IM, Christen W, et al
    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1809944.
    >> Share

  217. BHATT DL, Steg PG, Miller M, Brinton EA, et al
    Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812792.
    >> Share

  218. WIVIOTT SD, Raz I, Bonaca MP, Mosenzon O, et al
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    >> Share

  219. SCHWARTZ GG, Steg PG, Szarek M, Bhatt DL, et al
    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
    N Engl J Med. 2018 Nov 7. doi: 10.1056/NEJMoa1801174.
    >> Share

  220. ADRIAENSSENS T, Van de Werf F
    Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?
    N Engl J Med. 2018;379:1775-1776.
    >> Share

  221. THIELE H, Akin I, Sandri M, de Waha-Thiele S, et al
    One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    N Engl J Med. 2018;379:1699-1710.
    >> Share

    October 2018

  222. Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582-1584.
    >> Share

  223. MONTENEGRO MF, Lundberg JO, Weitzberg E
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583-4.
    >> Share

  224. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1583.
    >> Share

  225. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
    Cardiovascular Safety of Febuxostat.
    N Engl J Med. 2018;379:1582.
    >> Share

  226. DRAZEN JM
    Expression of Concern: Beltrami AP et al. Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. N Engl J Med 2001;344:1750-7 and Quaini F et al. Chimerism of the Transplanted Heart. N Engl J Med 2002;346:5-15.
    N Engl J Med. 2018 Oct 17. doi: 10.1056/NEJMe1813801.
    >> Share


  227. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    N Engl J Med. 2018;379:1486.
    >> Share


  228. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-1389.
    >> Share

  229. STEWART RAH
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1388.
    >> Share

  230. JENKINS D, Sievenpiper J, Jones P
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387-8.
    >> Share

  231. CORREIA LCL
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018;379:1387.
    >> Share

    September 2018
  232. FIELD ME, Page RL
    Another Shock for Sudden Death Prevention after Myocardial Infarction.
    N Engl J Med. 2018;379:1274-1275.
    >> Share

  233. OLGIN JE, Pletcher MJ, Vittinghoff E, Wranicz J, et al
    Wearable Cardioverter-Defibrillator after Myocardial Infarction.
    N Engl J Med. 2018;379:1205-1215.
    >> Share

  234. MCNEIL JJ, Wolfe R, Woods RL, Tonkin AM, et al
    Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    N Engl J Med. 2018 Sep 16. doi: 10.1056/NEJMoa1805819.
    >> Share

    August 2018
  235. ZANNAD F, Anker SD, Byra WM, Cleland JGF, et al
    Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
    N Engl J Med. 2018 Aug 27. doi: 10.1056/NEJMoa1808848.
    >> Share

  236. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    >> Share

  237. MAZER CD, Whitlock RP, Fergusson DA, Belley-Cote E, et al
    Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808561.
    >> Share


  238. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMoa1805971.
    >> Share

  239. HOFFMANN U, Udelson JE
    Imaging Coronary Anatomy and Reducing Myocardial Infarction.
    N Engl J Med. 2018 Aug 25. doi: 10.1056/NEJMe1809203.
    >> Share

  240. RAWSHANI A, Rawshani A, Franzen S, Sattar N, et al
    Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2018;379:633-644.
    >> Share

  241. WEINER RB, Hucker WJ, Meyersohn NM, Dudzinski DM, et al
    Case 25-2018: A 63-Year-Old Man with Syncope.
    N Engl J Med. 2018;379:670-680.
    >> Share

    July 2018
  242. XAPLANTERIS P, Fournier S, Pijls NHJ, Fearon WF, et al
    Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    N Engl J Med. 2018;379:250-259.
    >> Share

    June 2018
  243. CUERVO G, Viasus D, Carratala J
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2540.
    >> Share

  244. BUCKLEY LF
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539-40.
    >> Share

  245. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Ortiz A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    >> Share

  246. WIESSMAN M, Shlomai A
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2539.
    >> Share

  247. WAXMAN DA, Kanzaria HK, Schriger DL
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-9.
    >> Share


  248. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:2538-2541.
    >> Share

  249. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMc1806491.
    >> Share

  250. ESTRUCH R, Ros E, Salas-Salvado J, Covas MI, et al
    Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800389.
    >> Share

  251. ARBOINE L, Palacios JM
    Left Main Coronary Artery Aneurysm.
    N Engl J Med. 2018;378:e32.
    >> Share

    May 2018
  252. SHAPIRA OM
    Radial Artery as the Preferred Second Conduit for Coronary Bypass.
    N Engl J Med. 2018;378:2134-2135.
    >> Share

  253. JOHNSTON SC, Easton JD, Farrant M, Barsan W, et al
    Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    N Engl J Med. 2018 May 16. doi: 10.1056/NEJMoa1800410.
    >> Share

    April 2018
  254. GAUDINO M, Benedetto U, Fremes S, Biondi-Zoccai G, et al
    Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.
    N Engl J Med. 2018 Apr 30. doi: 10.1056/NEJMoa1716026.
    >> Share

  255. CAMPBELL BCV, Mitchell PJ, Churilov L, Yassi N, et al
    Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    N Engl J Med. 2018;378:1573-1582.
    >> Share

  256. BAIRD AE
    Paving the Way for Improved Treatment of Acute Stroke with Tenecteplase.
    N Engl J Med. 2018;378:1635-1636.
    >> Share

  257. ZHAO YT, Huang YS
    ECG Pattern Associated with Left Anterior Descending Coronary Artery Occlusion.
    N Engl J Med. 2018;378:e22.
    >> Share

  258. AMELOOT K, Daemen J, Van Mieghem N
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360-1.
    >> Share

  259. PAPPALARDO F, Bertoldi L
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1360.
    >> Share

  260. PASCERI V, Pelliccia F, Speciale G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359-60.
    >> Share

  261. FERREIRA RM, Salis LHA, e Silva NAS
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1359.
    >> Share

  262. FLEISSNER F, Haverich A, Warnecke G
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-9.
    >> Share

  263. SHARMA S, Lardizabal J
    PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358.
    >> Share


  264. PCI Strategies in Acute Myocardial Infarction with Cardiogenic Shock.
    N Engl J Med. 2018;378:1358-1361.
    >> Share

    March 2018
  265. LOSCALZO J, Roy N, Shah RV, Tsai JN, et al
    Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure.
    N Engl J Med. 2018;378:1043-1053.
    >> Share

  266. WHITE WB, Saag KG, Becker MA, Borer JS, et al
    Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    N Engl J Med. 2018 Mar 12. doi: 10.1056/NEJMoa1710895.
    >> Share

  267. LEE F, Maggiore P, Chung K
    Self-Management of an Inferior ST-Segment Elevation Myocardial Infarction.
    N Engl J Med. 2018;378:960-962.
    >> Share

    February 2018

  268. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    N Engl J Med. 2018;378:782.
    >> Share

    January 2018
  269. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    >> Share

  270. KWONG JC, Schwartz KL, Campitelli MA, Chung H, et al
    Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
    N Engl J Med. 2018;378:345-353.
    >> Share

  271. CAHILL TJ, Wijesurendra RS, Casadei B
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    >> Share

  272. HELFT G, Le Feuvre C, Zaman A
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:397.
    >> Share

  273. JEONG YH, Bae JS, Gurbel PA
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:396.
    >> Share

  274. AJANI AE
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-6.
    >> Share


  275. Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395-398.
    >> Share

  276. FAUCHIER L, Bisson A, Angoulvant D
    Rivaroxaban in Stable Cardiovascular Disease.
    N Engl J Med. 2018;378:395.
    >> Share

  277. WEBSTER MWI, Stables RH
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    >> Share

  278. SHAH R
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:299.
    >> Share

  279. VIJ A, Kodumuri V
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    >> Share

  280. BULLUCK H
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298.
    >> Share


  281. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:298-301.
    >> Share

  282. STONE GW
    Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    N Engl J Med. 2018;378:300-1.
    >> Share


  283. Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-202.
    >> Share

  284. LELLOUCHE F, Simon M, L'Her E
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:201.
    >> Share

  285. SAMADANI U, Affana CK
    Oxygen Therapy in Suspected Acute Myocardial Infarction.
    N Engl J Med. 2018;378:200-1.
    >> Share

  286. ROSENBAUM L
    Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring.
    N Engl J Med. 2018;378:101-103.
    >> Share

    December 2017
  287. IMPRIALOS KP, Stavropoulos K, Doumas M
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    >> Share

  288. HOLMAN RR, Bethel MA, Hernandez AF
    Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:2502.
    >> Share

  289. TSIARAS SV, Safi LM, Ghoshhajra BB, Lindsay ME, et al
    Case 39-2017. A 41-Year-Old Woman with Recurrent Chest Pain.
    N Engl J Med. 2017;377:2475-2484.
    >> Share

  290. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    >> Share

    November 2017

  291. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    >> Share

  292. RAJAGOPALAN S, Brook R
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098-9.
    >> Share

  293. FERNANDEZBALSELLS MM, Sojo-Vega L, Ricart-Engel W
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2098.
    >> Share

  294. BAGLIONI P
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-8.
    >> Share

  295. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    >> Share

  296. MAZER CD, Whitlock RP, Fergusson DA, Hall J, et al
    Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
    N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1711818.
    >> Share

  297. JACOB KA, Gianoli M, van Dijk D
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897-8.
    >> Share

  298. TAGGART DP, Puskas JD
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1897.
    >> Share

  299. JONES SG, Pullan MD, Kirmani BH
    Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1896-7.
    >> Share

  300. NOZAWA T, Imagawa T, Ito S
    Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease.
    N Engl J Med. 2017;377:1894-1896.
    >> Share


  301. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass.
    N Engl J Med. 2017;377:1898-1899.
    >> Share

    October 2017
  302. THIELE H, Akin I, Sandri M, Fuernau G, et al
    PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    N Engl J Med. 2017 Oct 30. doi: 10.1056/NEJMoa1710261.
    >> Share

  303. MONTONE RA, Minelli S
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595-6.
    >> Share

  304. AGGARWAL S, Pavlides G
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1595.
    >> Share

  305. BHATT DL
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1598-1599.
    >> Share

  306. DAVIES JE, Sen S, Escaned J
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1597-1598.
    >> Share

  307. PIJLS NHJ, De Bruyne B
    Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596.
    >> Share


  308. Instantaneous Wave-free Ratio versus Fractional Flow Reserve.
    N Engl J Med. 2017;377:1596-7.
    >> Share

    September 2017
  309. BOWMAN L, Hopewell JC, Chen F, Wallendszus K, et al
    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
    N Engl J Med. 2017;377:1217-1227.
    >> Share

  310. RIDKER PM, Everett BM, Thuren T, MacFadyen JG, et al
    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
    N Engl J Med. 2017;377:1119-1131.
    >> Share

  311. HOLMAN RR, Bethel MA, Mentz RJ, Thompson VP, et al
    Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017 Sep 14. doi: 10.1056/NEJMoa1612917.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016